Harvard Heart Letter

Rethinking low-dose aspirin

New studies shed light on the role of aspirin for people without a previous heart attack or stroke. It costs just pennies per pill, doesnít require a prescription, and may be lifesaving for some people. But daily low-dose aspirin doesnít make sense for everyone. Now, three major studies that examined the benefits and risks of this widely used drug may alter the advice about who should take aspirin. …

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In